Published in Exp Brain Res on January 01, 1988
Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A (2004) 3.45
Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A (2007) 2.19
Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft. Eur J Neurosci (2006) 1.32
Neonatal desensitization allows long-term survival of neural xenotransplants without immunosuppression. Nat Methods (2009) 1.07
Large animal models are critical for rationally advancing regenerative therapies. Regen Med (2006) 1.00
Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc Natl Acad Sci U S A (1994) 0.95
Optimization of the magnetic labeling of human neural stem cells and MRI visualization in the hemiparkinsonian rat brain. J Nanobiotechnology (2015) 0.85
Clonal human fetal ventral mesencephalic dopaminergic neuron precursors for cell therapy research. PLoS One (2012) 0.80
Behavioural consequences of neural transplantation. J Neurol (1994) 0.79
Neonatal desensitization does not universally prevent xenograft rejection. Nat Methods (2012) 0.79
Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease. Exp Neurol (2016) 0.78
Monoamine reuptake inhibitors in Parkinson's disease. Parkinsons Dis (2015) 0.78
The immunological challenges of cell transplantation for the treatment of Parkinson's disease. Brain Res Bull (2012) 0.76
Clinical application of neuronal grafts in Parkinson's disease. J Neurol (1994) 0.76
Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease. Stem Cell Rev (2016) 0.76
Transplantation into the human brain: present status and future possibilities. J Neurol Neurosurg Psychiatry (1989) 0.76
hESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation. Exp Neurol (2016) 0.75
Replacing Dopamine Neurons in Parkinson's Disease: How did it happen? J Parkinsons Dis (2017) 0.75
Core assessment program for intracerebral transplantations (CAPIT). Mov Disord (1992) 5.51
Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science (1997) 3.40
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 3.31
Neuron-specific enolase correlates with other prognostic markers after cardiac arrest. Neurology (2011) 3.15
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci (1999) 3.06
Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med (1990) 3.04
UBA domains of DNA damage-inducible proteins interact with ubiquitin. Nat Struct Biol (2001) 3.00
Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord (1999) 2.98
Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience (2008) 2.84
Cell replacement therapies for central nervous system disorders. Nat Neurosci (2000) 2.84
Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry (2000) 2.48
A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/. Nature (1994) 2.35
Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature (1987) 2.33
Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol (1998) 2.20
Learning deficit in BDNF mutant mice. Eur J Neurosci (1997) 2.20
Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci U S A (1997) 2.16
Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci (1999) 2.15
L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci (1998) 2.10
Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature (1999) 2.07
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med (1992) 2.01
A novel role of the budding yeast separin Esp1 in anaphase spindle elongation: evidence that proper spindle association of Esp1 is regulated by Pds1. J Cell Biol (2001) 1.95
Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience (2000) 1.95
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci (1995) 1.90
Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron (1991) 1.74
Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res (1979) 1.68
A postprophase topoisomerase II-dependent chromatid core separation step in the formation of metaphase chromosomes. J Cell Biol (1995) 1.65
Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat Med (1995) 1.61
Spatial learning and motor deficits in aged rats. Neurobiol Aging (1984) 1.60
UBA domains mediate protein-protein interactions between two DNA damage-inducible proteins. J Mol Biol (2001) 1.60
Obturator hernia: a new technique for repair. J R Coll Surg Edinb (1998) 1.58
The total antioxidant capacity of human serum measured using enhanced chemiluminescence is almost completely accounted for by urate. Ann Clin Biochem (1997) 1.57
The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol Scand Suppl (1974) 1.56
Mesencephalic dopamine neurons projecting to neocortex. Brain Res (1974) 1.54
Intrauterine death and circulating anticoagulant ("antithromboplastin"). Acta Med Scand (1975) 1.51
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol (1994) 1.50
Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat. Neuroscience (1985) 1.44
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons. Neurobiol Dis (2011) 1.43
Discordant neural tissue xenografts survive longer in immunoglobulin deficient mice. Transplantation (1999) 1.41
N-methyl-D-aspartate receptor-mediated increase of neurogenesis in adult rat dentate gyrus following stroke. Eur J Neurosci (2001) 1.39
Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals. Brain Res (1975) 1.39
Ventrolateral preoptic nucleus contains sleep-active, galaninergic neurons in multiple mammalian species. Neuroscience (2002) 1.38
The glyoxylic acid fluorescence histochemical method: a detailed account of the methodology for the visualization of central catecholamine neurons. Histochemistry (1974) 1.38
Cell therapy in Parkinson's disease - stop or go? Nat Rev Neurosci (2001) 1.34
Dopamine-containing neurons in the spinal cord: anatomy and some functional aspects. Ann Neurol (1983) 1.34
Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2. Development (2006) 1.33
Low fibrinolytic activity of veins during treatment with ethinylo estradiol. Acta Obstet Gynecol Scand (1971) 1.33
Purification of urokinase by affinity chromatography. Biochim Biophys Acta (1976) 1.32
Estrogen receptors in the human female lower uninary tract. Am J Obstet Gynecol (1981) 1.31
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol (2000) 1.30
Suppressed epileptogenesis in BDNF mutant mice. Exp Neurol (1995) 1.30
5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine. J Neurochem (1975) 1.29
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol (1997) 1.29
Purification of two Clostridium bacteriocins by procedures appropriate to hydrophobic proteins. Antimicrob Agents Chemother (1975) 1.28
Cyclin-dependent kinase and Cks/Suc1 interact with the proteasome in yeast to control proteolysis of M-phase targets. Genes Dev (1999) 1.28
The production of catecholamine-containing cells in vitro by young chick embryos: effects of "nerve growth factor" (NGF) and its antiserum. Neurobiology (1973) 1.28
Sleep fragmentation elevates behavioral, electrographic and neurochemical measures of sleepiness. Neuroscience (2007) 1.27
Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci U S A (1995) 1.26
The organization of tubero-hypophyseal and reticulo-infundibular catecholamine neuron systems in the rat brain. Brain Res (1973) 1.25
Identification of genes controlling growth polarity in the budding yeast Saccharomyces cerevisiae: a possible role of N-glycosylation and involvement of the exocyst complex. Genetics (1997) 1.25
Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts. Nature (1990) 1.24
Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain (2000) 1.24
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
The proton-translocating adenosine triphosphatase of the obligately anaerobic bacterium Clostridium pasteurianum. 1. ATP phosphohydrolase activity. Eur J Biochem (1979) 1.23
Regulation of brain-derived neurotrophic factor gene expression after transient middle cerebral artery occlusion with and without brain damage. Exp Neurol (1995) 1.22
Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res (1980) 1.21
Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol Scand Suppl (1973) 1.21
Organization of catecholamine neurons projecting to the frontal cortex in the rat. Brain Res (1978) 1.21
Clb5-associated kinase activity is required early in the spindle pathway for correct preanaphase nuclear positioning in Saccharomyces cerevisiae. J Cell Biol (1998) 1.19
Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator. Thromb Haemost (1985) 1.19
Caspase inhibitors increase short-term survival of progenitor-cell progeny in the adult rat dentate gyrus following status epilepticus. Eur J Neurosci (2001) 1.18
Survival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous system. Exp Neurol (1996) 1.18
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain (2000) 1.18
Dopamine-containing cells in sympathetic ganglia. Acta Physiol Scand (1970) 1.18
Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol Aging (1992) 1.17
Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture. Nature (1976) 1.17
Behavioral state control through differential serotonergic inhibition in the mesopontine cholinergic nuclei: a simultaneous unit recording and microdialysis study. J Neurosci (1998) 1.16
Clozapine treatment of psychosis associated with velo-cardio-facial syndrome: benefits and risks. J Intellect Disabil Res (2005) 1.16
Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle. Eur J Neurosci (1999) 1.16
The pbgPE operon in Photorhabdus luminescens is required for pathogenicity and symbiosis. J Bacteriol (2005) 1.15
Rupture of the uterus in Swedish departments of obstetrics, 1956-1961. Acta Obstet Gynecol Scand (1967) 1.15